Literature DB >> 19651494

Fitness cost of macrolide resistance in Campylobacter jejuni.

Feifei Han1, Shuaihua Pu, Fei Wang, Jianghong Meng, Beilei Ge.   

Abstract

Whether the acquisition of macrolide resistance imposes a biological burden on Campylobacter jejuni is unknown. In this study, C. jejuni macrolide-resistant mutants and the susceptible parent were compared by non-competitive growth, pair-wise competitive growth, and the ability to tolerate a chilling process commonly used in poultry processing plants. Overall, mutants demonstrated slower growth rates (average doubling time of 136 min vs. 112 min for the parent strain) and a lower survival ratio in the competitive growth experiment. However, mutants were equally competent in tolerating the chilling treatment. Our findings indicate that macrolide resistance incurs an obvious fitness cost in C. jejuni. However, the ability of macrolide-resistant C. jejuni mutants to tolerate the chilling process may render them equally capable of persisting in poultry products.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19651494     DOI: 10.1016/j.ijantimicag.2009.06.019

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  11 in total

1.  Emergence of multidrug-resistant Campylobacter species isolates with a horizontally acquired rRNA methylase.

Authors:  Yang Wang; Maojun Zhang; Fengru Deng; Zhangqi Shen; Congming Wu; Jianzhong Zhang; Qijing Zhang; Jianzhong Shen
Journal:  Antimicrob Agents Chemother       Date:  2014-06-30       Impact factor: 5.191

Review 2.  Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world?

Authors:  Alejandro Beceiro; María Tomás; Germán Bou
Journal:  Clin Microbiol Rev       Date:  2013-04       Impact factor: 26.132

3.  Impaired fitness and transmission of macrolide-resistant Campylobacter jejuni in its natural host.

Authors:  Taradon Luangtongkum; Zhangqi Shen; Virginia W Seng; Orhan Sahin; Byeonghwa Jeon; Peng Liu; Qijing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2011-12-19       Impact factor: 5.191

4.  Clinical and economic outcomes of decreased fluconazole susceptibility in patients with Candida glabrata bloodstream infections.

Authors:  Ingi Lee; Knashawn H Morales; Theoklis E Zaoutis; Neil O Fishman; Irving Nachamkin; Ebbing Lautenbach
Journal:  Am J Infect Control       Date:  2010-06-12       Impact factor: 2.918

5.  Mutational and transcriptomic changes involved in the development of macrolide resistance in Campylobacter jejuni.

Authors:  Haihong Hao; Zonghui Yuan; Zhangqi Shen; Jing Han; Orhan Sahin; Peng Liu; Qijing Zhang
Journal:  Antimicrob Agents Chemother       Date:  2012-12-28       Impact factor: 5.191

6.  Caught in the act: in vivo development of macrolide resistance to Campylobacter jejuni infection.

Authors:  J C Lindow; F Poly; D R Tribble; P Guerry; M P Carmolli; S Baqar; C K Porter; K K Pierce; M J Darsley; K S Sadigh; E A Dill; B D Kirkpatrick
Journal:  J Clin Microbiol       Date:  2010-06-16       Impact factor: 5.948

Review 7.  The Current State of Macrolide Resistance in Campylobacter spp.: Trends and Impacts of Resistance Mechanisms.

Authors:  Hannah Bolinger; Sophia Kathariou
Journal:  Appl Environ Microbiol       Date:  2017-05-31       Impact factor: 4.792

8.  Essential genome of Campylobacter jejuni.

Authors:  Rabindra K Mandal; Tieshan Jiang; Young Min Kwon
Journal:  BMC Genomics       Date:  2017-08-14       Impact factor: 3.969

9.  Microevolution of Campylobacter jejuni during long-term infection in an immunocompromised host.

Authors:  Clare R Barker; Anaïs Painset; Craig Swift; Claire Jenkins; Gauri Godbole; Martin C J Maiden; Timothy J Dallman
Journal:  Sci Rep       Date:  2020-06-22       Impact factor: 4.379

Review 10.  Resistance mechanisms in Campylobacter jejuni.

Authors:  Nicole M Iovine
Journal:  Virulence       Date:  2013-02-13       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.